Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned. - Wikidata - awgldk - TriplyDB

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

http://www.wikidata.org/entity/Q34314312

about

The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies Disease-modifying treatments for multiple sclerosis - a review of approved medications Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Aggressive multiple sclerosis: proposed definition and treatment algorithm.Structural properties of scaffolds: Crucial parameters towards stem cells differentiation MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report Multiple sclerosis: Prospects and promise.Cell-based therapy approaches: the hope for incurable diseases.Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.The future of multiple sclerosis treatments.Autologous hematopoietic cell transplantation in multiple sclerosis.Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.Modulating inflammation and neuroprotection in multiple sclerosis.Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up.Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.[Stem cell transplantation for multiple sclerosis. Hamburg experiences and state of international research].

P2860

Q26750597-B765084D-4D24-4602-ACE3-BB840A39C096 Q26777329-0104B52D-2330-48F8-9DEF-B54EF39F1EC8 Q28071992-45E54CEA-A129-4144-9DCF-877F1C1F7285 Q34468304-A6E2BE23-6310-4E29-8432-16AFA01A5611 Q34478828-3D7463D1-391D-4F07-9303-BEC36BC41305 Q35649782-86CEBE27-7A7F-4368-995C-A97C3809B964 Q36435150-4B750AA4-FD60-4E87-8970-5EEF0354E44E Q37003127-0A04183C-B4DF-4763-A0B8-A22303174334 Q37603718-9B7D955E-B39A-42CE-B18C-AEF8F7BCD5BE Q38129775-6ED4D1BC-F70D-42AF-8080-2589C9F5F5CE Q38265206-F40BD533-61A2-4AC6-983B-1582A8FA8CE0 Q38268313-F889F12F-7783-4EA5-A4F1-7BEA48403C85 Q38729214-08DE24A8-062D-4387-AE06-854994CB2D0B Q38808485-E5547676-56C4-428D-AEE7-EB92DA2FEEEF Q38818703-8096C11F-B676-4D2A-88A8-CA70EFA0AB34 Q38837567-E5F14CB7-B6D8-47BA-98C4-C6D06DF55D30 Q39249384-BF55D659-6275-4B2E-8C5D-114FB9E2CE38 Q39350409-B09B4D77-2AF8-4957-8F17-87AE214DE3D7 Q41236543-C82B4136-6A9D-4E28-B63D-13AD89EE141E Q48048274-941D8A9F-A265-42F6-AC3F-8F34D86633D6 Q52944830-BD03801D-8770-42C7-8575-73C52306D8E3

P2860

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

http://www.wikidata.org/entity/Q34314312

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@ast

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@en

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@nl

type

label

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@ast

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@en

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@nl

prefLabel

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@ast

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@en

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@nl

P1433

Q34314312-1FB1BF68-F130-4D78-B61E-B0E29AD923B8

P1476

Q34314312-13A34597-D5BF-41AB-9648-A36867AEE6FA

P2093

Q34314312-3A7AAD30-C5A4-40AF-8091-B7B58F0D5979

Q34314312-A4EA91EA-BE30-4790-8BB8-F5D24D6EE305

P2860

Q34314312-0139FCAE-44A6-4B22-AADF-623C7511861E

Q34314312-01A0319D-90BF-4AF6-81BA-B4FFD408968E

Q34314312-088C6E46-5F27-45A7-925E-233A79937BD2

Q34314312-0A6727CF-C393-47B7-8423-357DBA26C702

Q34314312-0E39F8A6-2015-4D9B-B6D6-CD90F7DEBB8D

Q34314312-1310518F-0CE6-49D7-9458-B40437D24006

Q34314312-15DA3177-EEBE-4D39-9582-B6697D1CC949

Q34314312-1628A520-D294-4ACD-80A3-60EF911C8806

Q34314312-1FF94871-C4F2-4D86-8D0D-312E7CD0E238

Q34314312-266B3358-AC27-4A5F-8BBE-81D439E78895

P2888

Q34314312-37636010-6191-44CB-A277-C81A5B718FB3

P304

Q34314312-C89FDCE0-41F0-4AC2-877B-DAB095C59638

P31

Q34314312-8633B1B4-B616-4171-A6E1-6447EDDD0F1C

Q34314312-e6014f7e-cce4-476b-be9b-c1e180082707

P356

Q34314312-36632BE8-419A-4E78-8AB1-23C3455B9912

P433

Q34314312-940AEE60-ABE1-435F-B745-31CF8E3CA94B

P478

Q34314312-EC553D3A-970C-4DF5-ADD5-5352C6129014

P577

Q34314312-41E5FCFC-DDCF-49E8-AA3E-52ECC4F51BF8

P698

Q34314312-551C78D6-5AB5-425D-AA12-BA270D81480D

P921

Q34314312-83F5E338-CE27-4317-8A16-63B30FB4E107

P932

Q34314312-D85F1E7F-0D6A-4F4A-A0BD-278F664894B1

P356

S13311-012-0162-5

P1433

Neurotherapeutics

P1476

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

@en

P2093

Harold L Atkins

http://www.w3.org/2001/XMLSchema#string

Mark S Freedman

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party.

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Evidence for a two-stage disability progression in multiple sclerosis

Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

P2888

s13311-012-0162-5

P304

68-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-012-0162-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23192675

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3557353

http://www.w3.org/2001/XMLSchema#string